Pacira Biosciences Inc
F:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
F:82P
|
US |
|
Robinhood Markets Inc
F:7KY
|
US |
|
E
|
EnQuest PLC
F:3EQ
|
UK |
|
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
ZA |
|
Schindler Holding AG
F:SHR0
|
CH |
|
E
|
Espey MFG and Electronics Corp
AMEX:ESP
|
US |
|
C
|
Currie Rose Resources Inc
F:CDVN
|
CA |
Wall St Price Targets
82P Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 82P is 21.95 EUR with a low forecast of 16.85 EUR and a high forecast of 28.94 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 82P's stock price target?
Price Target
21.95
EUR
According to Wall Street analysts, the average 1-year price target for 82P is 21.95 EUR with a low forecast of 16.85 EUR and a high forecast of 28.94 EUR.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 7 years is 6%.
What is the Gross Profit forecast for Pacira Biosciences Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
50%
The compound annual growth rate for Operating Income over the next 5 years is 50%.
What is the Pre-Tax Income forecast for Pacira Biosciences Inc?
Projected CAGR
163%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
64%
The compound annual growth rate for Net Income over the next 7 years is 64%.
